Ipsen has completed the acquisition of five consumer healthcare products from Sanofi, among which there are an analgesic for the treatment of moderate to severe pain, only sold in France, an antispasmodic (sold in the Czech Republic, Estonia, Hungary, Latvia, Poland and Slovakia), a laxative (sold in the Czech Republic), as well as two expectorants for cough and flu, sold respectively in Greece and the Republic of Ireland. This operation aims to strengthen Ipsen Consumer Healthcare portfolio in France and Central Europe with the strategic intent to further develop the OTx model in most geographies.